載入...
Bifunctional HDAC Therapeutics: One Drug to Rule Them All?
Histone deacetylase (HDAC) enzymes play crucial roles in epigenetic gene expression and are an attractive therapeutic target. Five HDAC inhibitors have been approved for cancer treatment to date, however, clinical applications have been limited due to poor single-agent drug efficacy and side effects...
Na minha lista:
| 發表在: | Molecules |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7583022/ https://ncbi.nlm.nih.gov/pubmed/32987782 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules25194394 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|